Q&A: What do we know about the Moderna Covid-19 vaccine?

What do we know about the Moderna vaccine, and what gaps are there in the data?
Q&A: What do we know about the Moderna Covid-19 vaccine?

A scientist working on the Moderna coronavirus vaccine (Screengrab/Moderna/PA)

US company Moderna has announced its coronavirus vaccine may be 94.5% effective against Covid-19.

The interim trial results come one week after Pfizer/BioNTech released early results for phase three of their vaccine study, suggesting their candidate has an efficacy of 90%.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Revoiced

Newsletter

Had a busy week? Sign up for some of the best reads from the week gone by. Selected just for you.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited